KILITCH DRUGS (INDIA) LTD.

NSE : KILITCHBSE : 524500ISIN CODE : INE729D01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE360.3010.7 (+3.06 %)
PREV CLOSE ( ) 349.60
OPEN PRICE ( ) 361.80
BID PRICE (QTY) 353.45 (30)
OFFER PRICE (QTY) 359.25 (10)
VOLUME 61
TODAY'S LOW / HIGH ( )360.25 361.80
52 WK LOW / HIGH ( )157 469.85
NSE357.0010.7 (+3.09 %)
PREV CLOSE( ) 346.30
OPEN PRICE ( ) 354.05
BID PRICE (QTY) 355.30 (2)
OFFER PRICE (QTY) 357.00 (29)
VOLUME 6335
TODAY'S LOW / HIGH( ) 349.00 363.60
52 WK LOW / HIGH ( )165.3 470
Peer Companies Price () Chg () Chg (%) EPS () TTM P/E Volume (000's) 1 Year Return (%)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.